Argenx Benefits Overview

Leads US and global regulatory strategy for biopharmaceutical products across development, filing, approval, commercialization, and post-approval stages. Serves as primary FDA contact, oversees IND/BLA/NDA submissions, briefing packages, responses, labeling, and regulatory interactions. Partners cross-functionally with medical, legal, quality, pharmacovigilance, and distribution teams, monitors regulatory and competitive landscapes, and supports product launches. The role requires strategic leadership, deep FDA and orphan-drug expertise, strong communication, project management, and team development capabilities.

Leads US and global regulatory strategy across the pharmaceutical product lifecycle, serving as the primary FDA contact and overseeing IND, BLA, and NDA submissions. Reviews regulatory documents, manages FDA responses, supports labeling and clinical study strategy, monitors regulatory changes and competitive precedents, and partners cross-functionally on product approvals and commercialization. Requires strong leadership, communication, project management, and biopharmaceutical regulatory experience, particularly involving orphan drugs and FDA interactions.

Lead the global commercial strategy, development, and launch readiness for FB102, a pipeline immunology product with multiple potential indications. Coordinate cross-functional teams across commercial, clinical, regulatory, medical, market access, manufacturing, and regional organizations. Develop lifecycle and product strategies, align clinical and manufacturing plans, gather regional market insights, prepare launches, build commercial teams, and maximize asset value. The role requires extensive pharmaceutical marketing experience, strategic leadership, stakeholder influence, and approximately 30% travel.